Just after Thanksgiving every year, Dr. Stamatia Destounis of Elizabeth Wende Breast Care (EWBC) heads out to The Radiological Society of North America (RSNA) Annual Meeting in Chicago, IL. She has been dedicating this week to the meeting for more than 30 years.
The yearly international meeting highlights the latest advances in radiology and displays research from around the world. At the meeting, Dr. Destounis meets with technology companies and gathers information on innovative technologies that will assist in the early detection of breast cancer. This, in turn, aids EWBC in bringing new equipment to the office, and thus the women of our region frequently participate in clinical research trials.
The RSNA meeting gives EWBC a platform to share important research and findings from our center. This year, our own Dr. Destounis will be presenting data findings on breast density and breast cancer risk study in collaboration with our Genetic Counselor, Jessica Salamone. This exciting research will show the effects of adding mammographic breast density into the Tyrer-Cuzick risk model, one of the risk assessment models used to calculate a patient’s lifetime risk of breast cancer.
Elizabeth Wende Breast Care strives to maintain its standing as a Center of Excellence and is always forefront of technological advancements in breast care. EWBC has active clinical trials and an institutional research department. Recent studies have included breast CT (computed tomography), 3D mammography, osteoporosis screening, breast density assessment. Current studies include ultrasound. Elizabeth Wende Breast Care has a long history of commitment to research that provides our patients access to the best technology possible for early detection of breast cancer.
Premenopausal Women More Affected by Adding Density to Risk Mode
Presentation by Stamatia Destounis, MD, FACR, and Jessica Salamone, CGC
Elizabeth Wende Breast Care, Rochester, NY